Cost-Effectiveness Analysis of Peginterferon Beta-1a in the Treatment of Relapsing-Remitting Multiple Sclerosis in Italy: Results of an Updated Analysis

• Diego Centonze,
• Sergio Iannazzo,
• Laura Santoni,
• Cecilia Saleri,
• Elisa Puma,
• Luigi Giuliani,
• Pier Luigi Canonico

Affiliations

Diego Centonze

IRCCS Neuromed, Pozzilli (IS), Italy & Laboratory of Synaptic Immunopathology, Tor Vergata University, Rome, Italy

Sergio Iannazzo

SIHS srl, Health Economics Consulting, Turin, Italy

Laura Santoni

Biogen Italia, Milan, Italy

Cecilia Saleri

Biogen Italia, Milan, Italy

Elisa Puma

Biogen Italia, Milan, Italy

Luigi Giuliani

SIHS srl, Health Economics Consulting, Turin, Italy

Pier Luigi Canonico

Department of Pharmaceutical Sciences, University of Piemonte Orientale “Amedeo Avogadro”, Novara, Italy